Transgene Announces Participation at Upcoming Investor Events

STRASBOURG, France--(BUSINESS WIRE)--

Regulatory News:

Transgene (Paris: TNG) today announced that management will participate in the upcoming events outlined below.

• SFAF Meeting: Transgene will present its annual 2015 results on March 9, 2016 at 11:30am. The meeting is being held at the Centre de Conference Etoile Honoré in Paris. A conference call and webcast in English will be held on the same day at 2:30pm.
• Cowen and Company 36th Annual Health Care Conference: The conference is being held in Boston, MA, March 7-9, 2016. Transgene will give a corporate presentation on March 9 at 8:00am. The presentation will be webcast.
• 9th Kempen Life Sciences Conference: Transgene will meet with institutional investors on April 7, 2016 in Amsterdam, The Netherlands.

About TransgeneTransgene S.A. (Euronext: TNG), part of Institut Mérieux, is a publicly traded French biopharmaceutical company focused on discovering and developing targeted immunotherapies for the treatment of cancer and infectious diseases. Transgene’s programs utilize viral vector technology with the goal of indirectly or directly killing infected or cancerous cells. The Company’s two lead clinical-stage programs are: TG4010 for non-small cell lung cancer and Pexa-Vec for liver cancer. The Company has several other programs in clinical and pre-clinical development. Transgene is based in Strasbourg, France, and has additional operations in Lyon, as well as satellite offices in China and the U.S. Additional information about Transgene is available at www.transgene.fr.

Société anonyme au capital de 88.195.793,51 € – R.C. Strasbourg B 317 540 581400 Boulevard Gonthier d’Andernach – 67400 Illkirch-Graffenstaden (France)Tél : + 33-03 88 27 91 00 - Fax : +33-03 88 27 91 11

View source version on businesswire.com: http://www.businesswire.com/news/home/20160302006105/en/

Transgene
Elisabetta Castelli, +33 (0)3 88 27 91 21
Director IR
[email protected]
or
MC Services
Raimund Gabriel, +49 89 210 228 30
[email protected]
or
Shaun Brown, +44 207 148 5998
[email protected]

Source: Transgene

You May Also Be Interested In

• Media Advisory: Ottawa Community Housing to Break Ground on 159 New Affordable Homes in Lowertown
• ACT Capital Advisors Represents Advanced Marketing Group, LLC on Its Acquisition by StoneX Commodity Solutions, LLC
• City of Carson Secures $370 Million Tesoro/Marathon Settlement, Strengthening City Finances Without a Tax Increase